title: Bacterial conjunctivitis.
abstract: BACKGROUND
  Most cases of conjunctivitis in adults are probably due to viral infection, but children are more likely to develop bacterial conjunctivitis than they are viral forms. The main bacterial pathogens are Haemophilus influenzae and Streptococcus pneumoniae in adults and children, and Moraxella catarrhalis in children. Contact lens wearers may be more likely to develop gram-negative infections. Bacterial keratitis occurs in up to 30 per 100,000 contact lens wearers.
  
  
  METHODS
  We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of empirical treatment in adults and children with suspected bacterial conjunctivitis? What are the effects of treatment in adults and children with bacteriologically confirmed bacterial conjunctivitis? What are the effects of treatment in adults and children with clinically confirmed gonococcal conjunctivitis? We searched: Medline, Embase, The Cochrane Library, and other important databases up to July 2011 (Clinical Evidence reviews are updated periodically; please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).
  
  
  RESULTS
  We found 44 systematic reviews, RCTs, or observational studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions.
  
  
  CONCLUSIONS
  In this systematic review we present information relating to the effectiveness and safety of the following interventions: ocular decongestants, oral antibiotics, parenteral antibiotics, saline, topical antibiotics, and warm compresses.
authors.affiliation: Department of Family Medicine, State University of New York-Upstate Medical University, Syracuse, New York, USA.
authors.forename: John
authors.initials: J
authors.lastname: Epling
mesh_terms: D000208:Acute Disease; D003231:Conjunctivitis / Q000188:drug therapy; D003234:Conjunctivitis, Bacterial / Q000188:drug therapy; D006069:Gonorrhea / Q000188:drug therapy; D006801:Humans; D009883:Ophthalmic Solutions / Q000008:administration & dosage; D014486:United States Food and Drug Administration
chemical_list: D009883:Ophthalmic Solutions